| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017808919 |
| P356 | DOI | 10.2165/00024677-200605010-00005 |
| P698 | PubMed publication ID | 16396517 |
| P2093 | author name string | Wanpen Vongpatanasin | |
| Dileep V Menon | |||
| P2860 | cites work | Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991 | Q22306385 |
| 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells | Q32065039 | ||
| Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
| HDL and the inflammatory response induced by LDL-derived oxidized phospholipids | Q34220276 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| Hormone replacement therapy and increased plasma concentration of C-reactive protein | Q40801238 | ||
| Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women | Q42506068 | ||
| Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q43492677 | ||
| Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women | Q43578108 | ||
| Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women | Q43645311 | ||
| Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study | Q43783590 | ||
| Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 | ||
| A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study | Q44147950 | ||
| Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects | Q44712632 | ||
| Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. | Q45007543 | ||
| The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women | Q45042716 | ||
| Body fat and sympathetic nerve activity in healthy subjects. | Q54202550 | ||
| P433 | issue | 1 | |
| P921 | main subject | circulatory system | Q11068 |
| estrogen | Q277954 | ||
| P304 | page(s) | 37-51 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Treatments in Endocrinology: guiding your management of endocrine disorders | Q15749555 |
| P1476 | title | Effects of transdermal estrogen replacement therapy on cardiovascular risk factors | |
| P478 | volume | 5 |
| Q36723311 | Anterior pituitary hormone replacement therapy--a clinical review |
| Q35653340 | Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapy |
| Q28200344 | C-reactive protein (CRP)-lowering agents |
| Q96231569 | C-reactive protein gene rs1205 polymorphism is associated with low-grade chronic inflammation in postmenopausal women |
| Q36430492 | Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial. |
| Q35785178 | Estrogen neuroprotection and the critical period hypothesis |
| Q35674373 | One more look at guidelines for primary and secondary prevention of cardiovascular disease in women |
| Q52879856 | Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women. |
| Q33693151 | Premature menopause and risk of neurological disease: basic mechanisms and clinical implications |
| Q37385612 | Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies. |
Search more.